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INTRODUCTION
Kidney graft survival can be improved by blood transfusion (1, 2, 3) and by
HLA-DR matching (h, 5, 6, 7 ) . Since cell mediated lympholysis (CML) reactivity
against the donor may be a good in vitro correlation of the homograft reaction,
we have investigated the influence of blood transfusion and HLA-DR matching on
CML reactivity. In this study CML activity of the kidney recipients against the
splenocytes of the specific kidney donor was studied serially at various times
before and after blood transfusion and renal a1lografting.
METHODS AND MATERIALS
We used a Standard CML assay, by which peripheral blood lymphocytes of the
recipients were sensitized in vitro against the splenocytes of the specific
donor, and against HLA-A, -B, -C and DR incompatible control cells of unrelated
healthy individuals. We measured the percentage of the donor specific and non-
specific lysis against PHA stitnulated blast cells.
Longitudinal and Single sample studies were performed. For the longitudinal
studies serial samples of peripheral blood lymphocytes were taken from the
recipients at several tiime intervals, as follows: a. before blood transfusion
b. at different times after blood transfusion c. on the day of transplantation
d. after different limes after transplantation jnd e. in the case of rejection,
after transplantectomy. All those samples, including the spieen cells of the
specific donor were frozen and stored in liquid nitrogen. All the combinations
with one particular patient were tested on the same day in the same experiment.
RESULTS
Of a total of 50 donor-recipient combinations: 23 were studied longitu-
dinal ly and 27 singly. Figure 1 shows an example of a long-term study of a
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patient who was immunized with one blood transfusion at 91 days before trans-
plantation. We showed that the donor-specific CML reactivity changed from 39%
before transplantation, to 14% two weeks after transplantation. This CML acti-
vity was donor-specific, because the anti-control cells lysis stayed at a con-
stant level. In figure 2 another example is given in which the specific anti-
donor lysis comes back to the pre-transfusion level. These two examples have
been taken from a total of 23 donor-recipient combinations studied longitu-
dinally. Both patients have a good functioning graft for more than one year.
The relationship between CML non-reactivity and renal allograft survival can
be more readily studied by calculating the decrement (or increment) in the %
CML in relation to the baseline level prior to blood transfusion.
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Fig. 1. Donor specific C.M.L. reactivity before and after transpiantation.
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This data is summarized in figure 3 for 23 patients studied longitudinally.
The increment of decrement is only shown for the most recent sample in the
longitudina] study.
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Fig. 3· The 3 cases in which the kidney was rejected, CML activity was tested
after transplantectomy.
In view of the blood transfusion poUcy, we investigated (in the total group
of 50 patients) whether there was a relationship between the number of blood
transfusions given and the occurence of CML in the most recent sample. In this
case non-reactivity was defined as a CML kill equal to or below 1 OS. We found
CML non-reactivity more frequently in multi-transfused patients, however the
data which are given in table 1 are not significant. An incidental observation
was that there was a transient non-specific rise in CML reactivity following a
single transfusion in non sensitized recipients (observed in 7 out of 23 cases)
TABLE 1
RELATION BETWEEN THE NUMBER 0F
BLOOD TRANSFUSIONS AND THE
OCCURENCE 0F CML NON-REACTIVITY
Blood transfusions
1 more than 1
CML + 7 7
8 22
(functioning grafts only)
TABLE 2
RELATION BETWEEN HLA-DR MATCHING
AND CML NON-REACTIVITY
HLA-DR mismatches
CML
Ο 1
3 7
5 13 13
(functioning grafts only)
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The important role of the HLA-DR matching beLween donor and recipient and
its in vitro relevance has been studied in the total group of 50 patients. The
results given in table 2 in which only the functioning grafLs are presented
indicate, that there is no clear cut relationship between HLA-DR matching and
CML negativity.
CONCLUSIONS
The importance of an in vitro correlation with the cadaveric kidney graft
surviva] has become a major immunologica1 topic. Many groups have already
investigated the occurence of direct and indirect CML activity in rena) allo-
graft donor-recipient combinations. With Special regard to our longitudinal
studies, the change in CML activity (e.g. decrement in lysis from pretrans-
fusion to post-transplantation level, figure 3) shows similarity to the obser-
vations of Wonigeit (8) and Thomas ( 9 ) . An important point is that the CML
non-reactivity could already be demonstrated within a short period after graf-
ting (figure 1 ) . The correlation between the number of blood transfusion and
the absolute % lysis against the donor is so far not significant, but if the
same trend continues in a more extensive study, a significant association might
ari se.
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